Risk factors for vancomycin-resistant Enterococcus faecalis bacteremia in hospitalized patients: An analysis of two case-control studies

American Journal of Infection Control

Volumn 34, Issue 7, 2006, Pages 447-451

  Furtado, Guilherme Henrique Campos ^a   Mendes, Rodrigo Elisandro ^a   Campos Pignatari, Antônio Carlos ^a   Wey, Sérgio Barsanti ^a   Medeiros, Eduardo Alexandrino Servolo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ADULT; ARTICLE; BACTEREMIA; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; MALE; RISK ASSESSMENT; RISK FACTOR; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTEREMIA; BRAZIL; CASE-CONTROL STUDIES; CATHETERS, INDWELLING; CROSS INFECTION; ENTEROCOCCUS FAECALIS; HUMANS; LENGTH OF STAY; LOGISTIC MODELS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VANCOMYCIN RESISTANCE; VENTILATORS, MECHANICAL;

EID: 33846168747     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2005.08.015     Document Type: Article

References (21)

1. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. A report from the NNIS System. Am J Infect Control 32 (2004) 470-485
2. Cereda R.F., Sader H.S., Jones R.N., Sejas L., Machado A.M., Zanatta Y.P., et al. Enterococcus faecalis resistant to vancomycin and teicoplanin (Van A phenotype) isolated from a bone marrow transplanted patient in Brazil. Braz J Infect Dis 5 (2001) 40-46
3. Furtado G.H.C., Martins S.T., Coutinho A.P., Soares G.M.M., Wey S.B., and Medeiros E.A.S. Incidence of vancomycin-resistant Enterococcus spp. at an university hospital in Brazil. J Public Health 39 (2005) 41-46
4. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20 (1995) 1126-1133
5. Lautenbach E., Bilker W.B., and Brennan P.J. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol 20 (1999) 318-323
6. Zaas A.K., Song X., Tucker P., and Perl T.M. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 35 (2002) 1139-1146
7. Facklam R.R., and Sahm D.A. Enterococcus. In: Murray P.R., Baron E.J., and Yolken R.H. (Eds). Manual of clinical microbiology. 6th ed. (1995), American Society for Microbiology, Washington, DC 308-314
8. National Committee for Clinical Laboratory Standards (NCCLS). M2-A8 Performance standards for antimicrobial disk susceptibility tests; approved standard-eight edition. Wayne, PA: 2003.
9. National Committee for Clinical Laboratory Standards (NCCLS). M7-A6 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standards. 6th ed. Wayne, PA: 2003.
10. Garner J.S., Jarvis W.R., Emory T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
11. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
12. McCabe W.R., and Jackson G.C. Gram negative bacteremia-etiology and ecology. Arch Intern Med 110 (1962) 847-855
13. Chow J.W., Fine M.J., Shlaes D.M., Quinn J.P., Hooper D.C., Johnson M.P., et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Medicine 115 (1991) 585-590
14. Dever L.L., and Handwerger S. Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice. Microb Drug Resist 2 (1996) 415-421
15. Whitman M.S., Pitsakis P.G., DeJesus E., Osborne A.J., Levison M.E., and Johnson C.C. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob Agents Chemother 40 (1996) 1526-1530
16. Shay D.K., Maloney S.A., Montecalvo M., Banerjee S., Wormser G.P., Arduino M.J., et al. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 172 (1995) 993-1000
17. Bhavnani S.M., Drake J.A., Forrest A., Deinhart J.A., Jones R.N., Biendenbach D.J., et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis 36 (2000) 145-158
18. Stosor V., Peterson L.R., Postelnick M., and Noskin G.A. Enterococcus faecium bacteremia. Does vancomycin resistance make a difference?. Arch Intern Med 158 (1998) 522-527
19. Lucas G.M., Lechtzin N., Puryear D.W., Yau L.L., Flexner C.W., and Moore R.D. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 26 (1998) 1127-1133
20. Peset V., Tallon P., Sola C., Sanchez E., Sarrion A., Perez-Belles C., et al. Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 19 (2000) 742-749
21. Garbutt J.M., Ventrapragada M., Littenberg B., and Mundy L.M. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis 30 (2000) 466-472